Clinical trials
Phase 1/2 Myocardial Infarction trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Unknown status | 10 |
| Terminated | 4 |
| Withdrawn | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stanford University | 2 |
| University of Rochester | 2 |
| Abbott Medical Devices | 1 |
| Academy Military Medical Science, China | 1 |
| Angioblast Systems | 1 |
| Capricor Inc. | 1 |
| Catharina Ziekenhuis Eindhoven | 1 |
| CellProthera | 1 |
| Center for Veterans Research and Education | 1 |
| China National Center for Cardiovascular Diseases | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myocardial Infarction | 35 |
| Heart Failure | 4 |
| Coronary Artery Disease | 3 |
| Heart Diseases | 3 |
| Myocardial Ischemia | 3 |
| ST Elevation Myocardial Infarction | 3 |
| Acute Coronary Syndrome | 2 |
| Cardiovascular Diseases | 2 |
| Inflammation | 2 |
| Mitral Valve Insufficiency | 2 |
Trials
Showing 26 to 35 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.